Tyche Industries
107.40
+1.40(+1.32%)
Market Cap₹110.14 Cr
PE Ratio16.16
IndustryHealthcare
Company Performance:
1D+1.32%
1M-7.45%
6M-24.95%
1Y-25.60%
5Y-33.56%
View Company Insightsright
More news about Tyche Industries
30Sept 25
Tyche Industries Overhauls Leadership Structure at 27th AGM
Tyche Industries Limited has made significant changes to its leadership structure following its 27th Annual General Meeting. Sandeep Gokaraju has been appointed as the new Managing Director for a five-year term. G Ganesh Kumar transitions from Chairman and Managing Director to Executive Director. Satya Srinivas Uppalapati joins as Executive Director. Srinivas Gelli's designation changes to Non-Executive Independent Director. Penumatsa Vijaya Lakshmi is re-appointed as Independent Director. The AGM also approved a 30% dividend, appointed a new Secretarial Auditor, and approved the Cost Auditor's remuneration.
 no imag found
05Sept 25
Tyche Industries Announces Major Leadership Changes and 27th AGM Details
Tyche Industries Limited has announced significant leadership changes following its Board meeting on September 5, 2025. Mr. G Ganesh Kumar steps down as Chairman cum Managing Director but continues as Executive Director. Mr. Sandeep Gokaraju is appointed as the new Chairman cum Managing Director, pending shareholder approval. Other key appointments include Mr. Satya Srinivas Uppalapati as additional Executive Director and Mr. Srinivas Gelli's elevation to Non-Executive Independent Director. The company's 27th AGM is scheduled for September 30, 2025, via video conferencing, with e-voting period set for September 27-29, 2025. The Board also adopted various reports and made decisions regarding dividend eligibility and cost-auditor remuneration.
 no imag found
14Aug 25
Tyche Industries Reports 9% Revenue Growth Amid Profit Decline in Q1 FY2026
Tyche Industries Limited, an API manufacturer, released Q1 FY2026 results. Total income increased 9% to ₹1,269.99 lakhs, but net profit fell 11% to ₹243.15 lakhs. EPS decreased from ₹2.66 to ₹2.37. Export sales dominated at ₹1,261.52 lakhs, over 99% of total sales. Net profit margin declined from 23.4% to 19.1%. The Board approved these results on August 12, 2025.
 no imag found
Tyche Industries
107.40
+1.40
(+1.32%)
1 Year Returns:-25.60%
Industry Peers
Sun Pharmaceutical
1,753.30
(-0.29%)
Divis Laboratories
6,026.00
(+0.21%)
Torrent Pharmaceuticals
4,256.60
(+1.01%)
Lupin
2,331.80
(+1.53%)
Dr Reddys Laboratories
1,259.60
(+0.50%)
Cipla
1,219.40
(-0.20%)
Zydus Life Science
886.40
(+3.00%)
Mankind Pharma
1,987.80
(+3.13%)
Aurobindo Pharma
1,281.60
(+0.23%)
Alkem Laboratories
5,297.00
(+2.96%)